2,585 results on '"Martini, Alberto"'
Search Results
2. Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
3. Development of a Multibody-Based Dynamic Model of the Rear Hitch Subsystem of an Agricultural Tractor
4. School visits to a physics research laboratory using virtual reality
5. Snowmass White Paper: Belle II physics reach and plans for the next decade and beyond
6. Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy: Optimizing the Number of Cores Taken
7. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group
8. Prostate Cancer–specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years’ Report from the European Association of Urology Robotic Urology Section Scientific Working Group
9. Long-term oncologic outcomes of robot-assisted radical cystectomy: update series from a high-volume robotic center beyond 10 years of follow-up
10. Reply to: Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimen
11. School Visits to a Physics Research Laboratory Using Virtual Reality
12. Novel Unscented Kalman Filter-based method to assess the thermal behavior of carbon brake discs for high-performance motorcycles
13. Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels
14. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
15. Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions
16. When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level
17. Track Finding at Belle II
18. Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens
19. S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
20. Patient experience and satisfaction after same-day discharge radical prostatectomy using a personalized, digital perioperative programme
21. Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis
22. Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Functional Outcomes in Males
23. Obesity and renal cell carcinoma: Biological mechanisms and perspectives
24. Lower Detrusor Apron–sparing Robot-assisted Radical Cystectomy and Intracorporeal Neobladder Reconstruction: Technique and Preliminary Outcomes
25. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
26. Magnetic Resonance Imaging–based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification
27. Long‐Term Maintenance of Clinical Responses by Individual Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Abatacept
28. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study
29. How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?
30. Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression
31. The obesity paradox in metastatic castration-resistant prostate cancer
32. Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosus
33. Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past?
34. Techniques to Improve Urinary Continence Outcomes Following Robot-Assisted Radical Prostatectomy
35. One-Dimensional Thermal Model and Temperature Estimation for a MotoGP Class Motorcycle Carbon Brake
36. Metabolic Syndrome, Obesity and Cancer Risk
37. The Future of Artificial Intelligence Applied to Perioperative Immunotherapy Trials: Renal Cell Carcinoma
38. Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial
39. One‐year outcomes of same‐day‐discharge robot‐assisted radical prostatectomy
40. Follow-up on Patients with Initial Negative mpMRI Target and Systematic Biopsy for PI-RADS ≥3 Lesions – An EAU-YAU Study Enhancing Prostate Cancer Detection.
41. MP16-07 URINARY MINIMAL RESIDUAL DISEASE DETECTION PREDICTS RECURRENCE IN BCG-UNRESPONSIVE NIMBC AND QUANTIFIES MOLECULAR RESPONSE TO NADOFARAGENE FIRADENOVEC
42. MP65-06 NOVEL COMBINATION THERAPY USING INTERFERON GENE THERAPY AND GEMCITABINE IN MURINE BLADDER CANCER CELL LINES
43. MP14-02 IDENTIFY THE OPTIMAL CANDIDATES FOR ADJUVANT ANDROGEN DEPRIVATION THERAPY AMONG PATIENTS WITH DETECTABLE PSA AFTER RADICAL PROSTATECTOMY
44. MP65-12 FOXF1: A NOVEL REGULATOR OF METASTASIS IN UROTHELIAL CARCINOMA OF THE BLADDER
45. MP65-05 SINGLE-CELL RNA SEQUENCING IDENTIFIES CHANGES IN TUMOR MICROENVIRONMENT INDUCED BY INTERFERON α GENE THERAPY IN MURINE BLADDER CANCER MODEL
46. MP61-05 WHAT ARE THE CAUSES OF DEATH AMONG MEN TREATED FOR PENILE CANCER?
47. Complications of immuno‐oncology care: what urologist should know
48. Corrigendum to “European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines” [Eur. Urol. 85 (2024) 17–31]
49. NOVEL COMBINATION THERAPY USING INTERFERON GENE THERAPY AND GEMCITABINE IN MURINE BLADDER CANCER CELL LINES
50. FOXF1: A NOVEL REGULATOR OF METASTASIS IN UROTHELIAL CARCINOMA OF THE BLADDER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.